Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fructose | 11 | 2026 | 60 | 4.910 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 17 | 2025 | 196 | 3.210 |
Why?
|
| Lipogenesis | 13 | 2025 | 61 | 2.410 |
Why?
|
| Glucose | 13 | 2026 | 851 | 2.340 |
Why?
|
| Liver | 14 | 2026 | 1788 | 2.020 |
Why?
|
| Transcription Factors | 10 | 2025 | 2402 | 1.570 |
Why?
|
| Nuclear Proteins | 8 | 2022 | 1210 | 1.460 |
Why?
|
| Insulin | 14 | 2021 | 1145 | 1.150 |
Why?
|
| Insulin Resistance | 12 | 2026 | 686 | 1.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2022 | 1457 | 1.020 |
Why?
|
| Fibroblast Growth Factors | 4 | 2025 | 172 | 0.900 |
Why?
|
| Lipase | 2 | 2021 | 90 | 0.780 |
Why?
|
| Triglycerides | 4 | 2022 | 602 | 0.780 |
Why?
|
| Succinic Acid | 1 | 2022 | 13 | 0.750 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 4 | 2021 | 400 | 0.720 |
Why?
|
| Animals | 37 | 2026 | 33725 | 0.700 |
Why?
|
| Systems Analysis | 1 | 2021 | 13 | 0.700 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 58 | 0.690 |
Why?
|
| Thermogenesis | 2 | 2025 | 57 | 0.670 |
Why?
|
| Metabolic Diseases | 2 | 2026 | 141 | 0.670 |
Why?
|
| Homeostasis | 6 | 2023 | 711 | 0.650 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 160 | 0.630 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 117 | 0.630 |
Why?
|
| Adipose Tissue | 3 | 2014 | 498 | 0.630 |
Why?
|
| Adipocytes | 4 | 2025 | 178 | 0.610 |
Why?
|
| Blood Glucose | 8 | 2025 | 1112 | 0.600 |
Why?
|
| Mice | 24 | 2026 | 18198 | 0.600 |
Why?
|
| Obesity | 12 | 2026 | 2416 | 0.580 |
Why?
|
| Fructose Intolerance | 2 | 2017 | 3 | 0.580 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 93 | 0.580 |
Why?
|
| Intestine, Small | 1 | 2021 | 291 | 0.570 |
Why?
|
| Insulin-Secreting Cells | 4 | 2022 | 133 | 0.530 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 618 | 0.500 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 2021 | 75 | 0.470 |
Why?
|
| Mice, Knockout | 10 | 2026 | 3819 | 0.470 |
Why?
|
| Membrane Proteins | 2 | 2021 | 1589 | 0.470 |
Why?
|
| Metabolic Syndrome | 2 | 2026 | 367 | 0.460 |
Why?
|
| Lipid Metabolism | 4 | 2025 | 382 | 0.460 |
Why?
|
| Energy Metabolism | 5 | 2026 | 803 | 0.450 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 831 | 0.420 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 1829 | 0.380 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 764 | 0.380 |
Why?
|
| Fatty Liver | 4 | 2025 | 221 | 0.370 |
Why?
|
| Signal Transduction | 5 | 2026 | 4663 | 0.360 |
Why?
|
| Humans | 39 | 2026 | 130511 | 0.320 |
Why?
|
| Proteins | 1 | 2015 | 1006 | 0.310 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 2319 | 0.300 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 179 | 0.280 |
Why?
|
| Dyslipidemias | 2 | 2022 | 249 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 9 | 2026 | 4699 | 0.270 |
Why?
|
| Fatty Acids | 2 | 2025 | 374 | 0.270 |
Why?
|
| Acetyl Coenzyme A | 2 | 2025 | 18 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 2 | 2025 | 1207 | 0.250 |
Why?
|
| Glycerophosphates | 1 | 2025 | 4 | 0.240 |
Why?
|
| Calorimetry, Indirect | 1 | 2026 | 64 | 0.230 |
Why?
|
| Glycolysis | 2 | 2016 | 173 | 0.230 |
Why?
|
| Organic Anion Transporters | 1 | 2025 | 23 | 0.230 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 3 | 2022 | 9 | 0.230 |
Why?
|
| Cholesterol, HDL | 3 | 2022 | 383 | 0.230 |
Why?
|
| Adipocytes, Brown | 1 | 2025 | 27 | 0.230 |
Why?
|
| Cell Communication | 1 | 2026 | 187 | 0.220 |
Why?
|
| Adipose Tissue, Brown | 1 | 2025 | 90 | 0.220 |
Why?
|
| Male | 23 | 2026 | 64586 | 0.220 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1800 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2025 | 2827 | 0.220 |
Why?
|
| RNA, Messenger | 3 | 2025 | 2544 | 0.210 |
Why?
|
| Calcium-Binding Proteins | 1 | 2025 | 322 | 0.210 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2025 | 129 | 0.210 |
Why?
|
| Hepatocytes | 3 | 2026 | 231 | 0.210 |
Why?
|
| Lipids | 2 | 2023 | 566 | 0.210 |
Why?
|
| Glucose Intolerance | 2 | 2016 | 80 | 0.200 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2025 | 263 | 0.200 |
Why?
|
| Adiposity | 2 | 2018 | 209 | 0.200 |
Why?
|
| Phospholipases A2, Calcium-Independent | 2 | 2021 | 19 | 0.200 |
Why?
|
| Acyltransferases | 2 | 2021 | 63 | 0.200 |
Why?
|
| Glucose Transporter Type 4 | 3 | 2014 | 23 | 0.200 |
Why?
|
| Sweetening Agents | 2 | 2026 | 37 | 0.190 |
Why?
|
| Weight Loss | 4 | 2022 | 535 | 0.190 |
Why?
|
| Succinates | 1 | 2022 | 14 | 0.190 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 319 | 0.190 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 43 | 0.180 |
Why?
|
| Lipoproteins | 2 | 2022 | 182 | 0.180 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2022 | 31 | 0.180 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 2 | 2021 | 10 | 0.180 |
Why?
|
| Serine Endopeptidases | 1 | 2023 | 197 | 0.180 |
Why?
|
| Body Weight | 2 | 2019 | 985 | 0.180 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 95 | 0.180 |
Why?
|
| Hexoses | 1 | 2021 | 10 | 0.170 |
Why?
|
| Keto Acids | 1 | 2021 | 50 | 0.170 |
Why?
|
| Rodentia | 1 | 2021 | 50 | 0.170 |
Why?
|
| Dietary Sugars | 1 | 2021 | 19 | 0.170 |
Why?
|
| Cohort Studies | 4 | 2021 | 5048 | 0.170 |
Why?
|
| Carbohydrate Metabolism | 1 | 2021 | 50 | 0.170 |
Why?
|
| Metabolomics | 1 | 2025 | 500 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2025 | 889 | 0.160 |
Why?
|
| Female | 19 | 2025 | 70545 | 0.160 |
Why?
|
| Fasting | 3 | 2017 | 303 | 0.160 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2020 | 7 | 0.160 |
Why?
|
| Haplotypes | 1 | 2021 | 517 | 0.160 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 18 | 0.160 |
Why?
|
| Food Deprivation | 1 | 2020 | 33 | 0.160 |
Why?
|
| Bariatric Surgery | 2 | 2019 | 153 | 0.150 |
Why?
|
| Liver Cirrhosis | 2 | 2018 | 901 | 0.150 |
Why?
|
| Glucagon | 1 | 2020 | 145 | 0.150 |
Why?
|
| Lipoproteins, VLDL | 2 | 2018 | 53 | 0.150 |
Why?
|
| Glucosides | 1 | 2020 | 55 | 0.150 |
Why?
|
| Mice, Inbred Strains | 1 | 2019 | 263 | 0.150 |
Why?
|
| Cholesterol | 2 | 2022 | 538 | 0.150 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 79 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2021 | 226 | 0.150 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 373 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 359 | 0.140 |
Why?
|
| Aging | 1 | 2026 | 1237 | 0.140 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 8 | 0.140 |
Why?
|
| Carboxypeptidases A | 1 | 2018 | 2 | 0.140 |
Why?
|
| Intestines | 1 | 2022 | 587 | 0.140 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2018 | 6 | 0.140 |
Why?
|
| Gastrectomy | 1 | 2019 | 104 | 0.140 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 4 | 0.140 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 22 | 0.140 |
Why?
|
| Pharmacogenomic Variants | 1 | 2018 | 38 | 0.140 |
Why?
|
| Colon | 1 | 2021 | 366 | 0.130 |
Why?
|
| Transcriptome | 1 | 2025 | 1097 | 0.130 |
Why?
|
| Sugars | 1 | 2018 | 17 | 0.130 |
Why?
|
| Beverages | 1 | 2017 | 99 | 0.130 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 137 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2021 | 917 | 0.130 |
Why?
|
| Machine Learning | 1 | 2021 | 380 | 0.130 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2016 | 17 | 0.120 |
Why?
|
| Diet | 2 | 2021 | 1113 | 0.120 |
Why?
|
| Eye Proteins | 1 | 2018 | 221 | 0.120 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2016 | 99 | 0.120 |
Why?
|
| Metformin | 1 | 2018 | 173 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2017 | 645 | 0.120 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2015 | 4 | 0.110 |
Why?
|
| Protein Isoforms | 2 | 2015 | 423 | 0.110 |
Why?
|
| Esters | 1 | 2014 | 29 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2021 | 3687 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 3422 | 0.100 |
Why?
|
| Rats | 4 | 2025 | 3368 | 0.100 |
Why?
|
| Phenotype | 2 | 2021 | 4455 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2015 | 233 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 710 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 826 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 616 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 94 | 0.080 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 55 | 0.080 |
Why?
|
| Risk Factors | 3 | 2025 | 11011 | 0.080 |
Why?
|
| Genotype | 2 | 2018 | 2589 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2882 | 0.080 |
Why?
|
| Vitamin D | 1 | 2012 | 193 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2010 | 48 | 0.080 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2010 | 38 | 0.080 |
Why?
|
| Protein Phosphatase 2C | 2 | 2021 | 59 | 0.080 |
Why?
|
| Adult | 9 | 2025 | 31115 | 0.070 |
Why?
|
| Hypertension | 1 | 2018 | 1352 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3751 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2012 | 1704 | 0.070 |
Why?
|
| Energy Intake | 1 | 2011 | 502 | 0.070 |
Why?
|
| Middle Aged | 9 | 2021 | 28420 | 0.070 |
Why?
|
| Leptin | 1 | 2010 | 218 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2022 | 6424 | 0.070 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 604 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3461 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1367 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 6058 | 0.060 |
Why?
|
| Cadaver | 2 | 2018 | 114 | 0.060 |
Why?
|
| Oxygen | 1 | 2010 | 548 | 0.060 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2026 | 32 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2018 | 297 | 0.060 |
Why?
|
| Hepatic Stellate Cells | 1 | 2026 | 30 | 0.060 |
Why?
|
| Carbon | 1 | 2006 | 100 | 0.060 |
Why?
|
| Biological Transport | 1 | 2006 | 329 | 0.060 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2025 | 59 | 0.060 |
Why?
|
| Cold Temperature | 1 | 2025 | 80 | 0.060 |
Why?
|
| Coenzyme A | 1 | 2025 | 6 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 491 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1371 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 4646 | 0.050 |
Why?
|
| Circadian Clocks | 1 | 2025 | 84 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 888 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 852 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3733 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3815 | 0.050 |
Why?
|
| Natriuretic Peptides | 1 | 2022 | 9 | 0.050 |
Why?
|
| Malonyl Coenzyme A | 1 | 2022 | 4 | 0.050 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2022 | 5 | 0.050 |
Why?
|
| Palmitates | 1 | 2022 | 17 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2026 | 348 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2022 | 74 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2022 | 69 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2022 | 76 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1109 | 0.050 |
Why?
|
| Particle Size | 1 | 2022 | 135 | 0.040 |
Why?
|
| Apolipoproteins B | 1 | 2022 | 142 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 724 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2025 | 436 | 0.040 |
Why?
|
| Feedback | 1 | 2022 | 143 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 265 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 1362 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 169 | 0.040 |
Why?
|
| Massachusetts | 1 | 2020 | 116 | 0.040 |
Why?
|
| Lipolysis | 1 | 2020 | 77 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2021 | 312 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2018 | 2460 | 0.040 |
Why?
|
| Body Composition | 2 | 2012 | 544 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2026 | 2897 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 149 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 25 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 198 | 0.030 |
Why?
|
| Organelle Biogenesis | 1 | 2018 | 18 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2018 | 65 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 63 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 142 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 97 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2018 | 119 | 0.030 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 56 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2018 | 157 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 299 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 294 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 253 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 268 | 0.030 |
Why?
|
| Gastric Bypass | 1 | 2017 | 97 | 0.030 |
Why?
|
| Keratin-18 | 1 | 2016 | 9 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 226 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 977 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 52 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2015 | 54 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 688 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1484 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 802 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2015 | 27 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 713 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 231 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1613 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2014 | 77 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 687 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 613 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 688 | 0.030 |
Why?
|
| Aged | 3 | 2018 | 20897 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 308 | 0.020 |
Why?
|
| Adolescent | 2 | 2025 | 20876 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 358 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2323 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1376 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 290 | 0.020 |
Why?
|
| Incidence | 1 | 2020 | 3336 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 508 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1319 | 0.020 |
Why?
|
| Housing, Animal | 1 | 2011 | 18 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 83 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 151 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 817 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 361 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 81 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 356 | 0.020 |
Why?
|
| Environment | 1 | 2011 | 149 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 10033 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3365 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1673 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6169 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 419 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2192 | 0.020 |
Why?
|
| Registries | 1 | 2016 | 1614 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 3038 | 0.020 |
Why?
|
| Metabolome | 1 | 2010 | 325 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1481 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6772 | 0.020 |
Why?
|
| Child | 1 | 2025 | 26233 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12851 | 0.010 |
Why?
|
| United States | 1 | 2016 | 12009 | 0.010 |
Why?
|